1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Biopsy Devices: Technology and Global Markets

Biopsy Devices: Technology and Global Markets

  • March 2016
  • -
  • BCC Research
  • -
  • 141 pages

This BCC Research report provides an in-depth study of the global biopsy devices methods by device, therapautic segments and geographic markets from 2012 through 2018, with five-year CAGR projections from 2015 through 2020. It focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others.

Use this report to:

Assess the dynamics that significantly impact the growth of the biopsy device market.
Estimate the biopsy device market and its subsegments from 2014 through 2020 by procedures and by geographical locations.
Provide segmented analysis based on devices, therapeutic segments and geographical locations.
Thoroughly evaluate market trends and technology assessments.

Highlights

The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.
The North American market should reach $868.8 million by 2020 from $663.9 million in 2015, at a CAGR of 5.5% from 2015 to 2020.
The European market should reach $785.3 million by 2020 from $586.0 million in 2015, at a CAGR of 6.0% from 2015 to 2020.

STUDY OBJECTIVES

The objectives of this report are to:

Assess the dynamics that have significant impact on the growth of the biopsy device market.
Estimate the biopsy device market and its subsegments from 2014 through 2019 by procedures and by geographical locations.
Analyze the key strategies, competitive insights and development of key companies in the market.
Provide segmented analysis based on devices, therapeutic segments and geographical locations.
Thoroughly analyze the market trends and technology assessments.
Study intensively the challenges that must be addressed and opportunities that can be leveraged by market participants.

STUDY BACKGROUND

The key criterion for successful cancer treatment is early diagnosis of the disease.
However, in the past it was extremely difficult for doctors to recommend a biopsy to patients that were considered low risk (even though “low risk” did not mean a patient did not need a biopsy for confirmation) because conventional biopsy methods involved complex technical issues along with increased trauma and stress among the patients.

However, with the increased adoption of noninvasive methods, the process is now being recommended for low-risk patients as well. Moreover, it became clear that the knowledge based on a biopsy also reduces the stress level and recovery period of the patient. Novel approaches to improve cancer diagnosis, including biopsy methods, are being introduced, which in turn are increasing the number of biopsy procedures being performed. Increased awareness and acceptance among patients are also driving the growth in the number of biopsies performed.

Key innovations are discussed in the report and market estimates are given for both conventional and advanced biopsy procedures. The report also profiles key market players that are focused on innovative biopsy procedures.

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global market for biopsy devices by device type, therapeutic segments and geographic markets. It discusses key devices such as breast biopsy devices, core needle biopsy (CNB) devices, fine needles, gastrointestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and nonthermal ablation techniques.

The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others. The report focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

Table Of Contents

Biopsy Devices: Technology and Global Markets
BIOPSY DEVICES: TECHNOLOGY AND GLOBAL MARKETS
CHAPTER 1 INTRODUCTION 2
STUDY OBJECTIVES 2
STUDY BACKGROUND 2
SCOPE OF THE REPORT 2
INTENDED AUDIENCE 3
METHODOLOGY AND INFORMATION SOURCES 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 3
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 EXECUTIVE SUMMARY 6
SUMMARY TABLE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020
($ MILLIONS) 7
CHAPTER 3 OVERVIEW OF BIOPSY DEVICE MARKET 10
VACUUM-ASSISTED BREAST BIOPSY 10
ADVANTAGES OF VAB TECHNIQUE 10
DISADVANTAGES OF VAB TECHNIQUE 11
LIVER BIOPSY TRENDS 11
LIVER DISEASE FACTS 11
PERCUTANEOUS LIVER BIOPSY 12
LAPAROSCOPIC SURGERY 12
PROSTATE BIOPSY TRENDS 13
IMAGE-GUIDED PROSTATE BIOPSY 13
RISKS OF BIOPSY OF THE PROSTATE 14
CANCER DIAGNOSTICS AND IMAGING 15
MAMMOGRAPHY 15
COLONOSCOPY 16
ENDOSCOPY 17
REGULATION OF BIOPSY DEVICES 18
U.S. REGULATION OF BIOPSY DEVICES 18
EU REGULATION OF BIOPSY DEVICES 20
Breast Cancer 20
TABLE 1 IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY
COUNTRY 20
Gastroenterology and Urology 21
REIMBURSEMENT POLICIES 21
U.S. REIMBURSEMENT FOR BREAST CANCER SCREENING 22
U.S. REIMBURSEMENT FOR BREAST RECONSTRUCTION OR PROSTHESIS 23
U.S. REIMBURSEMENT UNDER THE WHCRA 23
U.S. REIMBURSEMENT UNDER THE AFFORDABLE CARE ACT 23
MARKET DYNAMICS 24
DRIVERS 24
Increase in Prevalence of Chronic Diseases 24
Minimally Invasive Procedures as Compared with Other Techniques 24
Increased Public Awareness of Disease Screening 25
Increasing Aging Population 25
TABLE 2 GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%) 26
FIGURE 1 GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%) 26
Strong Reimbursement Policies in Developing Economies 26
Technological Advancements in Imaging Technology 27
RESTRAINTS 27
Increased Competition from Other Cancer Diagnostic Tests 27
High Price of Advanced Biopsy Devices 28
Availability of Advanced Diagnostic Services 28
OPPORTUNITIES/CHALLENGES 28
Tapping the Diagnostic Market Present in Emerging Economies 28
TABLE 3 PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES,
2014 (%) 29
FIGURE 2 PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES,
2014 (%) 29
CASE STUDIES 29
CASE STUDY 1: BREAST TOMOSYNTHESIS BIOPSY (2011) 29
Company Involved: Hologic Inc. 29
CASE STUDY 2: PET-GUIDED BREAST BIOPSY (2011) 30
Company Involved: Naviscan Inc. 30
CASE STUDY 3: BIOPSY USED TO INFILTRATE DUCTAL CARCINOMA 30
Company Involved: Toshiba 30
CHAPTER 4 BIOPSY DEVICE MARKET BY TYPE 33
TABLE 4 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($
MILLIONS) 33
BREAST BIOPSY DEVICES 33
STEREOTACTIC BIOPSIES 34
ULTRASOUND-GUIDED BIOPSIES 34
SURGICAL OR OPEN BIOPSIES 34
Surgical Biopsies with Needle Localization 35
TABLE 5 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020
($ MILLIONS) 35
TABLE 6 TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT 35
TABLE 7 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 36
VACUUM-ASSISTED BIOPSY DEVICES 36
TABLE 8 GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY
REGION, THROUGH 2020 ($ MILLIONS) 37
Breast Tissue Markers 38
Advantages of Vacuum-assisted Biopsy 38
Disadvantages of Vacuum-Assisted Biopsy 39
CAPITAL EQUIPMENT 39
IMAGE-GUIDED BREAST BIOPSIES 39
Ultrasound-Guided Breast Core Needle Biopsy 39
Stereotactic/MRI Breast Biopsy (Mammotome) 39
MAMMOGRAPHY 40
Digital Mammography 40
MAGNETIC RESONANCE IMAGING 41
Risks and Benefits of MRI 41
DISPOSABLE DEVICES 41
VAB Disposable Devices 42
Handheld Disposable Devices 42
Disposable Biopsy Punch 42
Punches with Plunger System 42
Punches without Plunger System 43
CORE NEEDLE BIOPSY 43
TABLE 9 GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 44
Core Needle Biopsy with Stereotactic Mammography 44
Advantages of Core Needle Biopsy 44
Disadvantages of Core Needle Biopsy 44
CNB Disposable Devices 45
Drapes 45
Table Drapes 45
Disposable Magnetic Drapes 45
Equipment Drape 45
Source Sleeve 45
Disposable Sterile Kit 46
CNB Tissue Markers 46
Advantages of CNB Tissue Markers 47
Disadvantages of CNB Markers 47
FINE NEEDLE ASPIRATION BIOPSY 47
TABLE 10 GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY
REGION, THROUGH 2020 ($ MILLIONS) 48
GASTROINTESTINAL BIOPSY 48
TABLE 11 GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 49
COLD FORCEPS 49
HOT FORCEPS 49
SOFT TISSUE BIOPSY NEEDLES 50
TABLE 12 GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION,
THROUGH 2020 ($ MILLIONS) 50
CORE NEEDLE BIOPSY NEEDLES 51
FINE-NEEDLE ASPIRATION NEEDLES 51
Advantages of FNA Needles 52
Disadvantages of FNA Needles 52
BRONCHIAL BIOPSY DEVICES 52
TABLE 13 GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 53
FORCEPS 53
Disposable 53
Reusable 54
TBNA NEEDLES 54
Conventional Needles 54
EBUS-TBNA 55
GYNECOLOGICAL BIOPSY DEVICES 55
TABLE 14 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 56
ENDOMETRIAL SAMPLERS 56
Functions of Endometrial Samplers 57
ROBOTIC GUIDANCE SYSTEMS 57
TABLE 15 GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION,
THROUGH 2020 ($ MILLIONS) 58
NEUROMATE (RENISHAW) 59
Benefits of Neuromate 59
Safety Features of Neuromate 59
PATHFINDER (PROSURGICS) 59
INNOMOTION (INNOMEDIC) 60
OTHERS 60
TABLE 16 GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 61
BIOPSY BRUSHES 61
BIOPSY CURETTES 61
TABLE 17 TYPES OF BIOPSY CURETTES 62
BIOPSY PUNCHES 62
TABLE 18 TYPES OF BIOPSY PUNCHES 62
CHAPTER 5 BIOPSY DEVICE MARKET BY THERAPEUTIC AREA 64
TABLE 19 GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA,
THROUGH 2020 ($ MILLIONS) 64
TABLE 20 GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES,
THROUGH 2020 (THOUSANDS) 65
BREAST BIOPSY 65
FINE-NEEDLE ASPIRATION BIOPSY 66
Fine-Needle Aspiration Biopsy for Palpable Growth 66
Guided FNAB for Nonpalpable Growth 66
CORE NEEDLE BIOPSY 66
VACUUM-ASSISTED BIOPSIES 66
SURGICAL BIOPSY 67
TABLE 21 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 67
GI BIOPSY 67
ENDOSCOPIC BIOPSY 68
FINE NEEDLE ASPIRATION BIOPSY 68
SURGICAL BIOPSY 68
TABLE 22 GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($
MILLIONS) 68
PROSTATE BIOPSY 68
LYMPH NODE BIOPSY 69
Laparoscopic Biopsy 69
Fine-Needle Aspiration Biopsy 69
Surgical Biopsy 69
TABLE 23 GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($
MILLIONS) 69
LIVER BIOPSY 70
NEEDLE BIOPSY 70
LAPAROSCOPIC BIOPSY 71
SURGICAL BIOPSY 71
TABLE 24 GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 71
LUNG BIOPSY 72
TABLE 25 FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE,
2013 (%) 72
FIGURE 3 FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE,
2013 (%) 72
ADVANTAGES OF LUNG BIOPSY 73
DISADVANTAGES OF LUNG BIOPSY 74
TABLE 26 GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 74
KIDNEY BIOPSY 74
TABLE 27 INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%) 74
FIGURE 4 INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%) 74
COMPLICATIONS OF BIOPSIES TO DETECT KIDNEY DISEASE 75
ADVANTAGES OF RENAL/KIDNEY BIOPSY 76
DISADVANTAGES OF RENAL/KIDNEY BIOPSY 76
TABLE 28 GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 76
GYNECOLOGICAL BIOPSY 77
TABLE 29 DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014 77
FIGURE 5 DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014 77
COMPLICATIONS OF GYNECOLOGICAL BIOPSY 78
TABLE 30 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 78
BIOPSY DEVICES USED TO DIAGNOSE OTHER DISEASES 79
PANCREATIC CANCER BIOPSY 79
Types of Biopsies Performed to Detect Pancreatic Cancer 79
Percutaneous Needle Biopsy 79
Endoscopic Retrograde Cholangiopancreatography 79
Endoscopic Ultrasound 80
BILE DUCT CANCER BIOPSY 80
THYROID BIOPSY 80
TABLE 31 GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 80
CHAPTER 6 BIOPSY DEVICE MARKET BY IMAGE GUIDING TECHNOLOGY 82
TABLE 32 GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 82
IMAGING TECHNOLOGIES USED IN GUIDING BIOPSIES 83
MRI-GUIDED BREAST BIOPSY 83
Advantages of MRI-Guided Biopsy 84
TABLE 33 GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 85
STEREOTACTIC-GUIDED BREAST BIOPSY 85
Advantages of Stereotactic-Guided Needle Biopsy 86
Disadvantages/Limitations of Stereotactic-Guided Needle Biopsy 86
TABLE 34 GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES
BY REGION, THROUGH 2020 ($ MILLIONS) 86
ULTRASOUND-GUIDED BIOPSY 87
LIVER BIOPSY 87
THYROID BIOPSY 88
PROSTATE BIOPSY 88
BREAST BIOPSY 88
TRENDS 88
TABLE 35 GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION,
THROUGH 2020 ($ MILLIONS) 89
COMPUTED TOMOGRAPHY 89
ADVANTAGES OF CT-GUIDED NEEDLE BIOPSY 90
DISADVANTAGES OF CT-GUIDED NEEDLE BIOPSY 90
LIMITATIONS OF CT-GUIDED NEEDLE BIOPSY 90
TABLE 36 GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 91
OTHERS 91
TABLE 37 GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 92
CHAPTER 7 END USER MARKETS FOR BIOPSY DEVICES 94
TABLE 38 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($
MILLIONS) 94
DIAGNOSTIC CENTERS 94
TABLE 39 GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS
BY REGION, THROUGH 2020 ($ MILLIONS) 96
HOSPITALS 96
TABLE 40 GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND
SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS) 96
TABLE 41 GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS
AND HOSPITALS, THROUGH 2020 ($ MILLIONS) 97
SPECIALIZED (CANCER) 97
TABLE 42 GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS
BY REGION, THROUGH 2020 ($ MILLIONS) 98
HOSPITALS 98
TABLE 43 GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION,
THROUGH 2020 ($ MILLIONS) 98
CHAPTER 8 COMPETITIVE LANDSCAPE 100
FIGURE 6 DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY
DEVICE COMPANIES, 2012-2015 (%) 100
PRODUCT LAUNCHES 101
FIGURE 7 DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY,
2012-2015 (%) 102
TABLE 44 KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015 102
PARTNERSHIPS AND COLLABORATIONS 105
FIGURE 8 DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY
BY COMPANY, 2012-2015 (%) 106
TABLE 45 PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY,
2012-2015 107
ACQUISITIONS 108
FIGURE 9 DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015
(%) 108
TABLE 46 COMPANY ACQUISITIONS , 2012-2015 109
EXPANSIONS 110
TABLE 47 COMPANY EXPANSIONS, 2012-2015 110
CHAPTER 9 BIOPSY DEVICE MARKET BY REGION 112
NORTH AMERICA 112
TABLE 48 NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($
MILLIONS) 113
EUROPE 113
TABLE 49 EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS) 114
ASIA-PACIFIC 114
TABLE 50 ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($
MILLIONS) 115
ROW 116
TABLE 51 ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS) 116
CHAPTER 10 PATENT ANALYSIS 118
FIGURE 10 U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY
DEVICES, 2013-2015 (%) 118
U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 118
FIGURE 11 U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%) 119
EUROPEAN PATENT ANALYSIS BY MARKET PARTICIPANT 119
FIGURE 12 EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%) 119
JAPANESE PATENT ANALYSIS BY MARKET PARTICIPANT 120
FIGURE 13 JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%) 120
CHAPTER 11 COMPANY PROFILES 123
ARGON MEDICAL DEVICES INC. 123
BIOPSY PRODUCT PORTFOLIO 123
TABLE 52 ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS 124
BECTON DICKINSON AND CO. (CAREFUSION CORP.) 124
BIOPSY PRODUCT PORTFOLIO 124
TABLE 53 BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS 125
TABLE 54 BECTON DICKINSON FINANCIALS ($ MILLIONS) 125
BOSTON SCIENTIFIC CORP. 125
BIOPSY PRODUCT PORTFOLIO 126
TABLE 55 BOSTON SCIENTIFIC: RECENT DEVELOPMENTS 126
TABLE 56 BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS) 127
C. R. BARD INC. 127
BIOPSY PRODUCT PORTFOLIO 127
TABLE 57 C. R. BARD FINANCIALS ($ MILLIONS) 128
CARDINAL HEALTH INC. 128
BIOPSY PRODUCT PORTFOLIO 128
TABLE 58 CARDINAL HEALTH: RECENT DEVELOPMENTS 129
TABLE 59 CARDINAL HEALTH FINANCIALS ($ MILLIONS) 129
COOK MEDICAL INC. 129
BIOPSY PRODUCT PORTFOLIO 130
TABLE 60 COOK MEDICAL: RECENT DEVELOPMENTS 130
DTR MEDICAL LTD. 131
BIOPSY PRODUCT PORTFOLIO 131
TABLE 61 DTR MEDICAL: RECENT DEVELOPMENTS 132
ETHICON ENDO-SURGERY INC. 132
BIOPSY PRODUCT PORTFOLIO 132
TABLE 62 ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS 133
TABLE 63 ETHICON ENDO-SURGERY (JOHNSON and JOHNSON) FINANCIALS ($
BILLIONS) 133
FUJIFILM HOLDINGS CORP. 133
BIOPSY PRODUCT PORTFOLIO 134
TABLE 64 FUJIFILM HOLDINGS: RECENT DEVELOPMENTS 134
TABLE 65 FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS) 134
HOLOGIC INC. 134
BIOPSY PRODUCT PORTFOLIO 135
TABLE 66 HOLOGIC: RECENT DEVELOPMENTS 135
TABLE 67 HOLOGIC FINANCIALS ($ MILLIONS) 136
INRAD INC. 136
BIOPSY PRODUCT PORTFOLIO 136
INTACT MEDICAL CORP. 137
BIOPSY PRODUCT PORTFOLIO 137
TABLE 68 INTACT MEDICAL: RECENT DEVELOPMENTS 137
LEICA BIOSYSTEMS (DEVICOR MEDICAL PRODUCTS) 137
BIOPSY PRODUCT PORTFOLIO 138
TABLE 69 LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS 138
MAUNA KEA TECHNOLOGIES 139
BIOPSY PRODUCT PORTFOLIO 139
TABLE 70 MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS 140
TABLE 71 MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS) 140
MDNA LIFE SCIENCES INC. (MITOMICS INC.) 140
BIOPSY PRODUCT PORTFOLIO 141
TABLE 72 MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS 141
MDXHEALTH INC. 142
BIOPSY PRODUCT PORTFOLIO 142
TABLE 73 MDXHEALTH: RECENT DEVELOPMENTS 143
MEDTRONIC 143
BIOPSY PRODUCT PORTFOLIO 144
TABLE 74 MEDTRONIC: RECENT DEVELOPMENTS 144
TABLE 75 MEDTRONIC FINANCIALS ($ MILLIONS) 145
SANARUS TECHNOLOGIES LLC 145
BIOPSY PRODUCT PORTFOLIO 145
TABLE 76 SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS 146
VERAN MEDICAL TECHNOLOGIES 146
BIOPSY PRODUCT PORTFOLIO 146
TABLE 77 VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS 147
CHAPTER 12 APPENDIX 149
TABLE 78 LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015 149
TABLE 79 LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015 151
TABLE 80 LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015 152

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 7
TABLE 1 IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY
COUNTRY 20
TABLE 2 GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%) 26
TABLE 3 PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES,
2014 (%) 29
TABLE 4 GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($
MILLIONS) 33
TABLE 5 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020
($ MILLIONS) 35
TABLE 6 TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT 35
TABLE 7 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 36
TABLE 8 GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY
REGION, THROUGH 2020 ($ MILLIONS) 37
TABLE 9 GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 44
TABLE 10 GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY
REGION, THROUGH 2020 ($ MILLIONS) 48
TABLE 11 GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 49
TABLE 12 GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION,
THROUGH 2020 ($ MILLIONS) 50
TABLE 13 GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 53
TABLE 14 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 56
TABLE 15 GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION,
THROUGH 2020 ($ MILLIONS) 58
TABLE 16 GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 61
TABLE 17 TYPES OF BIOPSY CURETTES 62
TABLE 18 TYPES OF BIOPSY PUNCHES 62
TABLE 19 GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA, THROUGH
2020 ($ MILLIONS) 64
TABLE 20 GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES,
THROUGH 2020 (THOUSANDS) 65
TABLE 21 GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 67
TABLE 22 GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($
MILLIONS) 68
TABLE 23 GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($
MILLIONS) 69
TABLE 24 GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH 2020
($ MILLIONS) 71
TABLE 25 FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE,
2013 (%) 72
TABLE 26 GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH 2020
($ MILLIONS) 74
TABLE 27 INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%) 74
TABLE 28 GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 76
TABLE 29 DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014 77
TABLE 30 GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 78
TABLE 31 GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 80
TABLE 32 GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 82
TABLE 33 GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 85
TABLE 34 GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES
BY REGION, THROUGH 2020 ($ MILLIONS) 86
TABLE 35 GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION,
THROUGH 2020 ($ MILLIONS) 89
TABLE 36 GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION, THROUGH
2020 ($ MILLIONS) 91
TABLE 37 GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION,
THROUGH 2020 ($ MILLIONS) 92
TABLE 38 GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($
MILLIONS) 94
TABLE 39 GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS BY
REGION, THROUGH 2020 ($ MILLIONS) 96
TABLE 40 GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND
SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS) 96
TABLE 41 GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS
AND HOSPITALS, THROUGH 2020 ($ MILLIONS) 97
TABLE 42 GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS BY
REGION, THROUGH 2020 ($ MILLIONS) 98
TABLE 43 GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION,
THROUGH 2020 ($ MILLIONS) 98
TABLE 44 KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015 102
TABLE 45 PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015 107
TABLE 46 COMPANY ACQUISITIONS , 2012-2015 109
TABLE 47 COMPANY EXPANSIONS, 2012-2015 110
TABLE 48 NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($
MILLIONS) 113
TABLE 49 EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS) 114
TABLE 50 ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS) 115
TABLE 51 ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS) 116
TABLE 52 ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS 124
TABLE 53 BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS 125
TABLE 54 BECTON DICKINSON FINANCIALS ($ MILLIONS) 125
TABLE 55 BOSTON SCIENTIFIC: RECENT DEVELOPMENTS 126
TABLE 56 BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS) 127
TABLE 57 C. R. BARD FINANCIALS ($ MILLIONS) 128
TABLE 58 CARDINAL HEALTH: RECENT DEVELOPMENTS 129
TABLE 59 CARDINAL HEALTH FINANCIALS ($ MILLIONS) 129
TABLE 60 COOK MEDICAL: RECENT DEVELOPMENTS 130
TABLE 61 DTR MEDICAL: RECENT DEVELOPMENTS 132
TABLE 62 ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS 133
TABLE 63 ETHICON ENDO-SURGERY (JOHNSON and JOHNSON) FINANCIALS ($ BILLIONS) 133
TABLE 64 FUJIFILM HOLDINGS: RECENT DEVELOPMENTS 134
TABLE 65 FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS) 134
TABLE 66 HOLOGIC: RECENT DEVELOPMENTS 135
TABLE 67 HOLOGIC FINANCIALS ($ MILLIONS) 136
TABLE 68 INTACT MEDICAL: RECENT DEVELOPMENTS 137
TABLE 69 LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS 138
TABLE 70 MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS 140
TABLE 71 MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS) 140
TABLE 72 MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS 141
TABLE 73 MDXHEALTH: RECENT DEVELOPMENTS 143
TABLE 74 MEDTRONIC: RECENT DEVELOPMENTS 144
TABLE 75 MEDTRONIC FINANCIALS ($ MILLIONS) 145
TABLE 76 SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS 146
TABLE 77 VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS 147
TABLE 78 LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015 149
TABLE 79 LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015 151
TABLE 80 LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015 152

LIST OF FIGURES

SUMMARY FIGURE GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020 ($
MILLIONS) 7
FIGURE 1 GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%) 26
FIGURE 2 PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES,
2014 (%) 29
FIGURE 3 FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE,
2013 (%) 72
FIGURE 4 INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%) 74
FIGURE 5 DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014 77
FIGURE 6 DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY DEVICE
COMPANIES, 2012-2015 (%) 100
FIGURE 7 DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY, 2012-2015
(%) 102
FIGURE 8 DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY BY
COMPANY, 2012-2015 (%) 106
FIGURE 9 DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015
(%) 108
FIGURE 10 U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY
DEVICES, 2013-2015 (%) 118
FIGURE 11 U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%) 119
FIGURE 12 EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%) 119
FIGURE 13 JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%) 120

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Report Synopsis This report by Future Market Insights (FMI) examines the ‘Liquid Biopsy Market’ for the period 2016–2026. The primary objective of the report is to offer updates and information ...

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive ...

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

Global liquid biopsies market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant ...


Download Unlimited Documents from Trusted Public Sources

Biopsy Industry in the Netherlands

  • December 2016
    10 pages
  • Biopsy  

  • Netherlands  

View report >

Biopsy Industry in the US

  • October 2016
    7 pages
  • Biopsy  

    Magnetic Resona...  

    Cancer  

  • United States  

View report >

Biopsy Industry in the US

  • August 2016
    2 pages
  • Biopsy  

  • United States  

    North America  

View report >

Related Market Segments :

Biopsy

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.